0001213900-22-009673.txt : 20220228 0001213900-22-009673.hdr.sgml : 20220228 20220228142002 ACCESSION NUMBER: 0001213900-22-009673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220223 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOUDENBERG MICHAEL CENTRAL INDEX KEY: 0001817884 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 22687485 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0306 4 2022-02-23 0 0001728328 InMed Pharmaceuticals Inc. INM 0001817884 WOUDENBERG MICHAEL C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 See Remarks Employee Stock Option (Right to Buy) 1.01 2022-02-23 4 A 0 5000 0.00 A 2027-02-22 Common shares 5000 96060 D The options were granted on 2/23/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant. SVP, Chem/Manufacturing/Control /s/ Bruce Colwill, attorney-in-fact for Mr. Michael Woudenberg 2022-02-28